Skip to main content

Table 1 Mean annual number of stable days and cost per patient by pharmaceutical treatment.

From: Erratum to: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

 

Paliperidone ER

Olanzapine

Risperidone

Quetiapine

Ziprasidone

Aripiprazole

Base case:

Cost (€)

7.030

7.034

7.082

8.321

7.807

7.713

Effectiveness

272.5

272.2

265.5

260.7

258.6

260.5

Incremental cost and effectiveness compared with paliperidone ER:

Cost (€)

-

4

52

1.291

777

683

Effectiveness

-

-0.3

-7.0

-11.8

-13.9

-12.0